Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Real World Study of Lapatinib Among Metastatic Breast Cancer Patients

Completed

Conditions: Breast Cancer

First Posted Date: 2019-03-28

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 242

Registration Number: NCT03894410

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Phase 3

Conditions: Capecitabine
Molecular Mechanisms of Pharmacological Action
Stomach Neoplasms
Digestive System Neoplasms
Apatinib
Stomach Diseases
Gastrointestinal Neoplasms
Neoplasms

Interventions: Drug: Apatinib
Drug: Capecitabine

First Posted Date: 2019-03-26

Last Posted Date: 2019-03-26

Lead Sponsor: Fudan University

Target Recruit Count: 242

Registration Number: NCT03889626

The Effects of Preoperatively Chewing Gum on Sore Throat After General Anaesthesia With a Laryngeal Mask

Phase 1

Conditions: Postoperative Sore Throat

Interventions: Other: swallow twice
Drug: chewed mint gum

First Posted Date: 2019-03-22

Last Posted Date: 2019-06-10

Lead Sponsor: Fudan University

Target Recruit Count: 70

Registration Number: NCT03885752

Locations: 🇨🇳
Ethics Committee of The Obstetrics and Gynecology Hospital, Fudan University,, Shanghai, China

Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis

Conditions: Colorectal Cancer
Lymph Node Metastases

Interventions: Diagnostic Test: Next-generation sequencing (NGS)

First Posted Date: 2019-03-11

Last Posted Date: 2019-03-11

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT03868215

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: Hypofractionated
Radiation: Conventional

First Posted Date: 2019-02-27

Last Posted Date: 2019-02-27

Lead Sponsor: Fudan University

Target Recruit Count: 1494

Registration Number: NCT03856372

Locations: 🇨🇳
Huangpu Branch, Shanghai ninth people's hospital, Shanghai, Shanghai, China
🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
🇨🇳
Suzhou Municipal hospital, Suzhou, Jiangsu, China

Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy

Not Applicable

Conditions: Rectal Cancer

Interventions: Drug: Indocyanine Green

First Posted Date: 2019-02-26

Last Posted Date: 2019-05-14

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT03854890

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer

Phase 2

Conditions: Extensive-stage Small Cell Lung Cancer

Interventions: Drug: anlotinib

First Posted Date: 2019-02-15

Last Posted Date: 2019-03-28

Lead Sponsor: Fudan University

Target Recruit Count: 70

Registration Number: NCT03841136

Locations: 🇨🇳
Cancer hospital Fudan University, Shanghai, Shanghai, China

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Not Applicable

Conditions: Hepatocellular Carcinoma

Interventions: Drug: lenvatinib
Procedure: TACE

First Posted Date: 2019-02-12

Last Posted Date: 2022-08-02

Lead Sponsor: Fudan University

Target Recruit Count: 297

Registration Number: NCT03838796

Locations: 🇨🇳
Huashan hospital, Shanghai, China

Physical and Psychological Effects of Different Temperature-controlled Breast Prostheses on Patients With Breast Cancer

Not Applicable

Completed

Conditions: External Breast Prostheses

Interventions: Other: different temperature-controlled breast prostheses

First Posted Date: 2019-02-05

Last Posted Date: 2019-02-05

Lead Sponsor: Fudan University

Target Recruit Count: 30

Registration Number: NCT03830294

UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer

Not Applicable

Conditions: Locally Advanced Rectal Cancer

Interventions: Diagnostic Test: Blood concentration check

First Posted Date: 2019-01-31

Last Posted Date: 2019-01-31

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT03824899

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy